EUVIMEDEUVIMED entdecken
Open Access

CAV1 —A Susceptibility Gene for Atrial Fibrillation: The Impact of Coding and Noncoding Variants

Kristin Rädecke iD, David Rheinert iD, Annette Löwen iD, Felix Wiedmann iD, Sabrina Diebold, Federica Diofano, Birgit Weiß iD, Ralph Röth iD, Stefanie Schmitteckert iD, Sebastian Clauss iD, Stefan Kääb iD, Steffen Just iD und 3 weitere

Journal of the American Heart Association · 03.02.2026 · 15 (3)

DOI: 10.1161/jaha.125.041586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 03.02.2026. Verfasst von Kristin Rädecke und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics University Hospital Heidelberg Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Caveolin 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia with a strong genetic predisposition. Genome‐wide association studies have highlighted CAV1 (caveolin 1), a caveolar protein involved in various signaling pathways, as a candidate for cardiac conduction disorders.

Methods

We explored the role of CAV1 in AF in various models to dissect possible disease mechanisms. First, CAV1 expression was examined together with the AF risk gene SHOX2 in a porcine model of induced AF. Then we screened a cohort of 282 patients with early‐onset AF to identify genetic variants within CAV1 and found 1 coding and 5 noncoding variants. The coding variant was functionally investigated in zebrafish, and a comprehensive analysis panel was applied to investigate the noncoding variants.

Results

In the porcine AF model, CAV1 and SHOX2 were significantly downregulated in the right atrium and atrioventricular node. Cardiac‐specific overexpression of the coding variant in zebrafish increased heart rate and caused fibrillatory waves and loss of the PR interval, supporting a pathogenic effect. Four of the 5 novel identified noncoding variants showed an association with AF and PR interval in published data sets, including 1 with genome‐wide significance. The noncoding variants localized to binding sites of transcription factors EOMES, RFX5, TEAD4 and MAX. Luciferase reporter gene assays demonstrated that 3 variants significantly altered the ability of those transcription factors to activate reporter gene expression.

Conclusions

This work underscores CAV1 as an AF susceptibility gene and highlights the critical role of coding and noncoding variants in AF disease mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCaveolin 1AnimalsZebrafishGenetic Predisposition to DiseaseHumansDisease Models, AnimalFemaleGenome-Wide Association StudyZebrafish ProteinsAnimals, Genetically ModifiedSwineMaleAtrioventricular NodeHeart AtriaTranscription FactorsGenetic Variation

Stichwörter der Autor:innen

SHOX2atrial fibrillationcaveolin 1noncoding variants

Substanzen

Caveolin 1CAV1 protein, humanZebrafish ProteinsTranscription Factors

Autor:innen und Institutionen

  • Institute of Human Genetics University Hospital Heidelberg Germany.
  • DZHK (German Centre for Cardiovascular Research) Partner Site Heidelberg/Mannheim Heidelberg Germany.
  • Department of Cardiology University Hospital Heidelberg Germany.
  • CR, Heidelberg Center for Heart Rhythm Disorders University Hospital Heidelberg Germany.
  • Clinic for Internal Medicine II - Molecular Cardiology University Hospital Ulm Germany.
  • nCounter Core Facility, Institute of Human Genetics University Hospital Heidelberg Germany.

ORCID-Profile: Kristin Rädecke, David Rheinert, Annette Löwen, Felix Wiedmann, Birgit Weiß, Ralph Röth, Stefanie Schmitteckert, Sebastian Clauss, Stefan Kääb, Steffen Just, Constanze Schmidt, Gudrun A Rappold, Sandra Hoffmann

Zitieren

APA

Rädecke, K., Rheinert, D., Löwen, A., Wiedmann, F., Diebold, S., Diofano, F., Weiß, B., Röth, R., Schmitteckert, S., Clauss, S., Kääb, S., Just, S., Schmidt, C., Rappold, G. A., & Hoffmann, S. (2026). CAV1 —A Susceptibility Gene for Atrial Fibrillation: The Impact of Coding and Noncoding Variants. Journal of the American Heart Association, 15(3). https://doi.org/10.1161/jaha.125.041586

Vancouver

Rädecke K, Rheinert D, Löwen A, Wiedmann F, Diebold S, Diofano F, et al. CAV1 —A Susceptibility Gene for Atrial Fibrillation: The Impact of Coding and Noncoding Variants. Journal of the American Heart Association. 2026;15(3). doi:10.1161/jaha.125.041586

BibTeX
@article{Rdecke2026,
  author = {Rädecke, Kristin and Rheinert, David and Löwen, Annette and Wiedmann, Felix and Diebold, Sabrina and Diofano, Federica and Weiß, Birgit and Röth, Ralph and Schmitteckert, Stefanie and Clauss, Sebastian and Kääb, Stefan and Just, Steffen and Schmidt, Constanze and Rappold, Gudrun A and Hoffmann, Sandra},
  title = {CAV1 —A Susceptibility Gene for Atrial Fibrillation: The Impact of Coding and Noncoding Variants},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {3},
  doi = {10.1161/jaha.125.041586}
}
Kostenlos starten →